EP0837675A2 - Methods and compositions for preparing soft gelatin capsules having shells resistant to permeation by fill materials - Google Patents
Methods and compositions for preparing soft gelatin capsules having shells resistant to permeation by fill materialsInfo
- Publication number
- EP0837675A2 EP0837675A2 EP96919128A EP96919128A EP0837675A2 EP 0837675 A2 EP0837675 A2 EP 0837675A2 EP 96919128 A EP96919128 A EP 96919128A EP 96919128 A EP96919128 A EP 96919128A EP 0837675 A2 EP0837675 A2 EP 0837675A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- gelatin
- layer
- barrier layer
- fill material
- shell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000463 material Substances 0.000 title claims abstract description 86
- 239000007903 gelatin capsule Substances 0.000 title claims abstract description 58
- 239000000203 mixture Substances 0.000 title claims description 39
- 238000000034 method Methods 0.000 title claims description 16
- 108010010803 Gelatin Proteins 0.000 claims abstract description 73
- 239000008273 gelatin Substances 0.000 claims abstract description 72
- 229920000159 gelatin Polymers 0.000 claims abstract description 72
- 235000019322 gelatine Nutrition 0.000 claims abstract description 72
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 72
- 239000002775 capsule Substances 0.000 claims abstract description 19
- 230000004888 barrier function Effects 0.000 claims description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- -1 polyethylene copolymer Polymers 0.000 claims description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 230000002209 hydrophobic effect Effects 0.000 claims description 18
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 238000013508 migration Methods 0.000 claims description 15
- 230000005012 migration Effects 0.000 claims description 15
- 150000001298 alcohols Chemical class 0.000 claims description 11
- 238000005266 casting Methods 0.000 claims description 10
- 239000004200 microcrystalline wax Substances 0.000 claims description 10
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 10
- 239000002131 composite material Substances 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 150000004668 long chain fatty acids Chemical class 0.000 claims description 8
- 239000004698 Polyethylene Substances 0.000 claims description 7
- 238000005538 encapsulation Methods 0.000 claims description 7
- 229930195733 hydrocarbon Natural products 0.000 claims description 7
- 150000002430 hydrocarbons Chemical class 0.000 claims description 7
- 229920000573 polyethylene Polymers 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 239000001993 wax Substances 0.000 claims description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 6
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 claims description 6
- 229920006242 ethylene acrylic acid copolymer Polymers 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 239000004034 viscosity adjusting agent Substances 0.000 claims description 6
- 239000012188 paraffin wax Substances 0.000 claims description 5
- 229920005638 polyethylene monopolymer Polymers 0.000 claims description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- OVGRCEFMXPHEBL-UHFFFAOYSA-N 1-ethenoxypropane Chemical compound CCCOC=C OVGRCEFMXPHEBL-UHFFFAOYSA-N 0.000 claims description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 3
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 3
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims description 3
- 239000005977 Ethylene Substances 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 3
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims description 3
- IAQRGUVFOMOMEM-UHFFFAOYSA-N but-2-ene Chemical group CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 claims description 3
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000000178 monomer Substances 0.000 claims description 3
- 238000006116 polymerization reaction Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 4
- 229940063557 methacrylate Drugs 0.000 claims 3
- 239000004215 Carbon black (E152) Substances 0.000 claims 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims 1
- 229940044600 maleic anhydride Drugs 0.000 claims 1
- 229940063559 methacrylic acid Drugs 0.000 claims 1
- 239000010410 layer Substances 0.000 description 122
- 239000011257 shell material Substances 0.000 description 42
- 239000007788 liquid Substances 0.000 description 15
- 239000000306 component Substances 0.000 description 14
- 238000009472 formulation Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 7
- 238000001125 extrusion Methods 0.000 description 6
- 239000010408 film Substances 0.000 description 6
- 235000019271 petrolatum Nutrition 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 230000002411 adverse Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229940092738 beeswax Drugs 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019809 paraffin wax Nutrition 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000012164 animal wax Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000011344 liquid material Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 239000012165 plant wax Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 241000212342 Sium Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 229940117913 acrylamide Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- QHZOMAXECYYXGP-UHFFFAOYSA-N ethene;prop-2-enoic acid Chemical compound C=C.OC(=O)C=C QHZOMAXECYYXGP-UHFFFAOYSA-N 0.000 description 1
- 229920006226 ethylene-acrylic acid Polymers 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229940059904 light mineral oil Drugs 0.000 description 1
- YAFQFNOUYXZVPZ-UHFFFAOYSA-N liproxstatin-1 Chemical compound ClC1=CC=CC(CNC=2C3(CCNCC3)NC3=CC=CC=C3N=2)=C1 YAFQFNOUYXZVPZ-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- HCTVWSOKIJULET-LQDWTQKMSA-M phenoxymethylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 HCTVWSOKIJULET-LQDWTQKMSA-M 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Definitions
- This invention relates to the field of gelatin capsules containing a fill material comprising a liquid phase. More specifically, this invention relates to gelatin capsules compris ⁇ ing a gelatin shell rendered impervious to migration of the fill material into the gelatin shell. Description of the Related Art
- Soft gelatin capsules or softgels are predominantly used to contain liquids wherein the active ingredients are present in the dissolved or suspended state.
- the liquids employed as a portion of the fill materials commonly include vegetable oils, animals oils, mineral oils, liquid hydrocarbons, etheral oils, polyethyl ⁇ ene glycol . Fats and waxes are also commonly used or added to the fill to modify its consistency.
- the soft gelatin capsule fill material may contain at most about 8% water by weight.
- liquid materials migrate into and/or interact with the gelatin forming the shell of the capsule. This migration or interaction has a harmful effect on the stability and structure of the gelatin capsule.
- water a solvent for the proteinaceous material forming gelatin, dissolves gelatin.
- fill materials for gelatin capsules may only be prepared to include a liquid phase comprising at most about 8% water by weight.
- Similar problems are encountered using other liquids in fill materials for gelatin capsules. Polyethylene glycol, ethanol, propylene glycol and similar low molecular weight, polar solvents also adversely interact with the gelatin shell. These problems are described in U.S. Patent Nos. 4,888,239 and 4,780,316.
- the invention encompasses gelatin capsules having a barrier that effectively isolates the gelatin shell and its components from the fill material.
- the invention provides gelatin capsules comprising a multilayer shell having an outer layer and at least one inner layer acting as a barrier.
- the fill material which comprises a hydrophilic or a hydrophobic component.
- the outer layer of the gelatin capsule typically comprises gelatin while the barrier (in certain cases the layer in contact with the fill) is formed from a material resistant to migration of hydrophilic or hydrophobic components from the fill material into the outer layer.
- the barrier in certain cases the layer in contact with the fill
- a variety of combinations of the outer gelatin layer adhered to other layers including the barrier are encompassed within the scope of the invention.
- the invention thus provides gelatin capsules capable of containing a fill material comprising in excess of 8% by weight water.
- the resulting gelatin capsules comprising water have excellent long-term stability and are capable of encapsulating a variety of liquid fill materials.
- the invention further encom ⁇ passes gelatin capsules capable of containing a fill material having a tendency to absorb water or other shell materials without any of the shell components from being absorbed by the fill.
- the resulting gelatin capsules can be prepared to include a variety of solutions, lotions, emulsions, creams, gels or suspen ⁇ sions.
- the invention further provides gelatin capsules capable of encapsulating within the fill material a variety of components that may adversely affect the physical or chemical stability of the gelatin capsule shell.
- the fill material may include pharmaceuticals such as synthetic drugs and proteins, various antibodies and enzymes, and vitamins and minerals, fine chemicals, industrial chemicals, solvents, insecticides, etc.
- the invention further provides a method for manufacturing gelatin capsules where the gelatin capsules are capable of containing a liquid fill material that is also capable of interacting adversely with the gelatin shell .
- the method comprises forming a gelatin ribbon, the gelatin ribbon having an outer layer comprising gelatin and an inner layer resistant to migration of hydrophilic and hydrophobic materials; preparing a fill material to comprise a system comprising a liquid that may adversely interact with gelatin; and encapsulating the fill
- the invention also provides composite films comprising a gelatin layer and a barrier layer where the barrier layer is resistant or impervious to migration of hydrophilic and hydrophobic materials across the barrier.
- the composite films i.e., the multilayer gelatin ribbons, prepared according to the invention to have a gelatin layer and at least one barrier layer can also be used as sheets to wrap a package or a variety of articles.
- FIGURE 1 is a cross-sectional diagram of a die having a single slot coat-hanger cavity configuration showing port 2 and die lip 1;
- FIGURE 2 is a cross-sectional diagram of a coextrusion feedblock die showing ports 4, 4a and 4b, and exit port 3;
- FIGURE 3 is a cross-sectional diagram of a multi-slot multiexit die showing ports 5, 5a and 5b, and die lip 6;
- FIGURES 4 and 5 are cross-sectional diagrams of multi- manifold single exit dies showing ports 7, 7a and 7b, and die lip 8.
- the gelatin capsules of the invention comprise a shell and a fill material disposed within the shell.
- the shell comprises at least one outer layer and at least one inner layer functioning as a barrier layer.
- the outer layer typically comprises gelatin while the barrier layer is formed from a material that is resistant to permeation by the materials forming the fill material.
- the shell includes a barrier layer as an inner layer that prevents migration of the liquid material from the fill into the outer gelatin layer.
- the barrier layer may be adjacent to the fill material and in contact with the fill material or may be isolated from the fill material by an interposed layer of gelatin or other material. Further, the barrier layer may comprise a plurality of layers of material impervious or resistant to permeation by the fill material.
- the fill material comprises any of a variety of liquid components in addition to various solid materials.
- the liquid may be a hydrophilic liquid or may be a hydrophobic, i.e., lipophilic, liquid.
- Representative hydrophilic components include water, C ⁇ -C 3 alcohols, polyethylene glycols, glycerol, propylene glycol, C ⁇ C j acids, saturated polyglycolyzed C 8 -C 10 glycerides, glycofural, diethylene glycol monoethyl ether, high fructose corn syrup, maltose syrup, maltitol syrup, glucose syrup, sugar syrup, honey, and sorbitol .
- hydrophobic or lipophilic components include hydrocarbons such as, for example, mineral oils, petrolatum, polyethylene waxes, and microcrystalline waxes, synthetic esters such as, for example, isopropyl myristate; natural esters such as, for example, vegetable oils, animal fats and lanolin; natural long-chain alcohols; synthetic chain alcohols; natural long-chain fatty acids; synthetic long-chain fatty acids; ethers such as, for example polyoxypropylenes; silicones such as, for example, substituted or unsubstituted silicones; mixed plant waxes such as candelilla; mixed animal waxes such as bees wax; or mixtures of any of these components.
- hydrocarbons such as, for example, mineral oils, petrolatum, polyethylene waxes, and microcrystalline waxes
- synthetic esters such as, for example, isopropyl myristate
- natural esters such as, for example, vegetable oils, animal fats and lanolin
- natural long-chain alcohols such as
- the shell comprises an outer layer and at least one barrier layer that may be the inner layer in contact with the capsule fill material. These layers are discrete layers that preferably are blended at their interface to improve adherence between layers.
- the invention encompasses a variety of combinations of an outer gelatin layer and inner layers where at least one inner layer is a barrier layer.
- the other inner layers may be formed from gelatin or other suitable material, such as, for example, agar, pectin, alginate, starch, carrageenan, cellulose or similar polysaccharides or other film forming polymers, such as, for example, shellac or whey protein.
- the capsule shell is a multi-layer composite of an outer layer and at least one inner layer.
- the composite may be a bi-layer, a tri- layer, or a quad-layer shell.
- the shell may be multi ⁇ layer composite having more than four layers.
- the particular properties of the desired final product may be altered by using such combinations. Examples of these alternative combinations are the following: Outer layer Inner layers gelatin barrier gelatin barrier barrier gelatin barrier gelatin barrier gelatin gelatin barrier gelatin barrier gelatin barrier gelatin barrier gelatin barrier agar barrier gelatin agar gelatin barrier
- the multilayer ribbons for use in the invention are from about 0.01 to 0.07, preferably from about 0.02 to 0.05, and more preferably from about 0.03 to 0.035, inches in thickness.
- the layer in contact with the fill material may be a layer of gelatin, optionally modified as described below, to protect and isolate the barrier layer during manufacturing of the ribbon and the final gelatin capsule.
- This gelatin layer may be a protective or lubricating layer isolating the tacky barrier from the encapsu ⁇ lation apparatus.
- the outer layer comprises gelatin and a plasticizer for the gelatin.
- the gelatin mass used to prepare the capsule shell is made according to conventional methods using traditional compo ⁇ nents.
- the gelatin may optionally include an embrittlement inhibiting composition comprising materials such as a mixture of sorbitol and one or more sorbitans. See U.S. Patent No. 4,780,316.
- the gelatin may optionally include a tackifier or a viscosity modifier. Examples of tackifiers and viscosity modifiers are ethylene acrylic acid copolymer and amylose, respectively.
- a preferred gelatin outer layer comprises gelatin, glycerin as a plasticizer, and water.
- glycerin as a plasticizer
- water in preferred embodiments of a dry
- the gelatin present in the outer layer is about 40-70% by weight of the outer layer; glycerin is from about 20-40% by weight of the outer layer; and water is about 5-15% by weight of the outer layer.
- the layer in contact with the fill material is a layer of gelatin
- that gelatin layer may optionally be modified by the addition of hydrophobic components.
- suitable hydrophobic components include colloidal silicas, modified silicas, silicones, modified silicones, magnesium stearate, oxidized polyethylene homopolymer, polyethylene homopolymer, paraffin wax, or mixtures of these materials.
- the barrier layer of the shell comprises any of a variety of homopolymers or copolymers.
- Such polymers can be derived from the polymerization of a monomer from the group consisting of acryl- amide, acrylic acid, acrylonitrile, caprolactones, ethylene, furan, maleic anhydride, methacrylate, methacrylic acid, methacry ⁇ late, methylpropylene, styrene, vinyl acetate, vinyl alcohol, vinyl chloride, vinyl ethylether, vinyl propylether, vinyl pyrrolidone, salts of any of the above-mentioned acids or mixtures of these materials.
- the inner layer may also comprise a paraffin wax.
- the barrier layer further may comprise hydrocarbons such as polyethylene waxes or microcrystalline waxes, synthetic esters such as isopropyl myristate, natural esters such as vegetable oils, animal fats, or lanolin, natural long-chain alcohols, synthetic long-chain alcohols, natural long-chain fatty acids, synthetic long-chain fatty acids, ethers such as for example polyoxypropylenes, silicones, mixed plant waxes, mixed animal waxes such as bees wax or mixtures thereof.
- hydrocarbons such as polyethylene waxes or microcrystalline waxes, synthetic esters such as isopropyl myristate, natural esters such as vegetable oils, animal fats, or lanolin, natural long-chain alcohols, synthetic long-chain alcohols, natural long-chain fatty acids, synthetic long-chain fatty acids, ethers such as for example polyoxypropylenes, silicones, mixed plant waxes, mixed animal waxes such as bees wax or mixtures thereof.
- microcrystalline wax is meant a solid
- Such solid hydrocarbons have molecular weights from about 490 to 800 and viscosities from about 45 to 120 Saybolt Universal Seconds (SUS) at 210°F (99°C) .
- Preferred inner layers of the shell comprise paraffin waxes, polyethylene homopolymers or polyethylene copolymers.
- a parti ⁇ cularly preferred inner layer comprises ethylene acrylic acid copolymer available from Allied Signal, Inc., Morristown, N.J. and microcrystalline wax available from Witco Corporation, Greenwich, CT.
- ethylene acrylic acid copolymer is about 50-90% by weight of the inner layer and a microcrystalline wax is about 10- 50% by weight of the inner layer.
- Other preferred inner layers have the following compositions:
- the shell is formed in a manner such that each layer adheres securely to every other layer.
- the gelatin layer i.e., the outer layer
- adheres to the inner layer i.e., the barrier layer.
- the shell according to the invention is prepared from a multi-layer, e.g., a bi-layer or tri-layer, ribbon that comprises materials that allow for processing into a soft gelatin capsule on a rotary die encapsulation machine without delamination or separa ⁇ tion of the various layers of the multilayer ribbon.
- a multi-layer e.g., a bi-layer or tri-layer, ribbon that comprises materials that allow for processing into a soft gelatin capsule on a rotary die encapsulation machine without delamination or separa ⁇ tion of the various layers of the multilayer ribbon.
- ⁇ 10- adhesion is defined as adhesion between the layers sufficient to prevent separation or delamination during all stages of the encapsulation process.
- the barrier layer material is selected such that it is impervious to hydrophilic materials such as for example water, polyethylene glycols, glycerol, propylene glycol, various C ⁇ -C 3 alcohols, etc.
- the barrier layer must also be impervious to a variety of hydrophobic or lipophilic vehicles such as fractionated coconut oil, light mineral oil, petrolatum, etc.
- the materials forming the shell must act as a uniform single ribbon of shell material, i.e., the materials must possess properties similar to that of a typical gelatin ribbon.
- Each inner layer, including the barrier layer, when adhered to the outer layer must have suffi ⁇ cient elasticity, strength and heat sealing abilities to allow processing of the multilayer material into a capsule on a rotary die encapsulating machine.
- each layer to another layer may be enhanced by incorporat ⁇ ing tackifiers into the gelatin mass, or the inner layer or barrier layer formulations, or each layer material; alternatively, it may be enhanced by physically modifying the layers during the manufacturing process.
- tackifiers and viscosity modifiers include ethylene acrylic acid copolymer and amylose, respectively.
- suitable material for preparing a multi-layer shell of gelatin and at least one barrier material either the gelatin mass or barrier material may be modified by the addition of viscosity modifiers in either the gelatin mass or the barrier fill formulation.
- -11- these materials may be modified by physically changing the manufacturing process.
- the apparatus to prepare the inventive gelatin capsules are rotary die encapsulation machines modified such that the inner and outer layers of the capsule shell simultaneously are formed by coextrusion on a casting drum using a coextrusion feedblock and a single manifold, single exit sheet die.
- Preferred embodiments include machines modified such that the inner and outer layers are coextruded on a casting drum using a multi manifold, multi exit sheet die.
- Another alternative includes preparing the inner and outer layers sequentially by extruding onto casting drum using a single-manifold, single exit coat-hanger slot die.
- the gelatin ribbon is formed by simultaneously coextruding the inner and outer layers on a casting drum.
- extrusion dies suitable for preparing the multilayer films of the invention are typically capable of (1) forcing the melted gelatin and barrier materials into thin films, (2) maintaining the melted materials at a constant temperature; and (3) metering the melted materials at a constant pressure and rate to the die land to prepare a film of a uniform gauge.
- extrusion dies suitable for use in the invention include those listed in the following table:
- a coextrusion feedblock such as that shown in Figure 2 is mounted on a coat-hanger type die such as the one shown in Figure 1, such that the exit port 3 is adjacent the feed port 2.
- the coextrusion feedblock and die are mounted adjacent a casting drum to provide the drum with a film of material .
- the ports provide the die lip with single-layer, bi-layer or multilayer material, depending on the configuration.
- the die is mounted on a rotary die encapsulation apparatus such that the die lips are adjacent a casting drum and provides the casting drum with a thin film of material .
- ⁇ 13- Bi-layer soft gelatin capsules are manufactured on a rotary die encapsulation apparatus using the materials shown below in Table I.
- the bi-layer (gelatin-barrier) ribbons are formed by a coextrusion technique.
- This bi-layer ribbon is formed by a multi- manifold multi-exit die.
- Formulation 1 A PEG 400 solution containing 20% w/w of water was encapsulated in the bi-layer capsule with the shell composition described in Table I. Soft gelatin capsules with good seals were obtained.
- Formulation 2 A PEG solution containing 40% w/w of water was encapsulated in the bi-layer capsule with the shell composition described in Table I. Soft gelatin capsules with good seals were obtained.
- Formulation 3 A bi-layer capsule with the shell composition described in Table I containing a 100% purified water as fill was prepared. Soft gelatin capsules with good seals were obtained.
- Formulation 4 A bi-layer capsule with the shell composition
- Formulation 7 A water-in-oil emulsion containing 56.3% w/w of water, 10% w/w POE glycerol sorbitan, isostearate, 3% w/w beeswax, 3% w/w lanolin, 11% w/w cap- rylic/capric triglyceride, 11% w/w squalane, 3% w/w
- 1% w/w hydroxypropyl cellulose, and 41% w/w ethoxy- diglycol was encapsulated in a bi-layer capsule having the shell composition described in Table 1. Soft gelatin capsules with good seals were ob ⁇ tained.
- Bilayer and gelatin-barrier composite ribbons are prepared to comprise a barrier layer containing a 70:30 blend of ethylene acrylic acid copolymer and microcrystalline wax where the gelatin and barrier layers have thicknesses of 0.019 and 0.033 inches, respectively.
- a gelatin layer 0.032 inches thick is prepared utilizing conventional gelatin ribbon casting methods. Water vapor permeation rates for each ribbon are shown in Tables II and III below:
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Laminated Bodies (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Materials For Medical Uses (AREA)
- Artificial Filaments (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47289595A | 1995-06-07 | 1995-06-07 | |
US472895 | 1995-06-07 | ||
PCT/US1996/009145 WO1996040083A2 (en) | 1995-06-07 | 1996-06-06 | Methods and compositions for preparing soft gelatin capsules having shells resistant to permeation by fill materials |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0837675A2 true EP0837675A2 (en) | 1998-04-29 |
Family
ID=23877340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96919128A Withdrawn EP0837675A2 (en) | 1995-06-07 | 1996-06-06 | Methods and compositions for preparing soft gelatin capsules having shells resistant to permeation by fill materials |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0837675A2 (ja) |
JP (1) | JPH11506785A (ja) |
KR (1) | KR19990022443A (ja) |
CN (1) | CN1186429A (ja) |
AU (1) | AU6154696A (ja) |
BR (1) | BR9608608A (ja) |
CA (1) | CA2222120A1 (ja) |
CZ (1) | CZ381897A3 (ja) |
HU (1) | HUP9900858A2 (ja) |
IL (1) | IL122422A0 (ja) |
NZ (1) | NZ310708A (ja) |
PL (1) | PL323790A1 (ja) |
SK (1) | SK164897A3 (ja) |
WO (1) | WO1996040083A2 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6333047B1 (en) | 1997-05-09 | 2001-12-25 | Daiichi Kasei Co., Ltd. | Molded capsule superior in strength and stability and method for preparing same |
JP3188649B2 (ja) * | 1997-05-09 | 2001-07-16 | 株式会社第一化成 | カプセル |
ES2235337T3 (es) * | 1997-07-09 | 2005-07-01 | Swiss Caps Rechte Und Lizenzen Ag | Procedimiento y dispositivo para fabricar una forma farmaceutica multicapa, fisiologicamente tolerable. |
GB2398499B (en) * | 2000-02-16 | 2004-11-24 | Bioprogress Technology Ltd | Two layer capsules |
CN1111419C (zh) * | 2000-07-05 | 2003-06-18 | 宋令春 | 一种治疗心脑血管中风和中风先兆症状的药物及其制备方法 |
EP1498117A1 (en) * | 2003-07-15 | 2005-01-19 | Pfizer GmbH Arzneimittelwerk Gödecke | A pharmaceutical gelatin-capsule or gelatin containing capsule preparation showing an improved stability, a process for making the capsules and a process for improving the stability of gelatin-capsules |
NL2000247C2 (nl) * | 2006-09-25 | 2008-03-26 | Drie Mollen Holding B V | Vloeistofhoudende capsule. |
CN101596174B (zh) * | 2009-07-13 | 2011-04-06 | 北京航洋胶囊技术有限公司 | 一种软胶囊及其制备方法 |
CN102552209A (zh) * | 2012-01-06 | 2012-07-11 | 安徽黄山胶囊股份有限公司 | 一种双层空心胶囊和多层肠溶空心胶囊 |
CN103550065B (zh) * | 2013-10-26 | 2015-01-28 | 中山市凯博思淀粉材料科技有限公司 | 一种复合挤出法生产淀粉基软胶囊的方法 |
US20150209360A1 (en) * | 2014-01-30 | 2015-07-30 | Orbz, Llc | Oral caffeine delivery composition |
CN107361392B (zh) * | 2017-07-26 | 2019-10-25 | 云南芯韵科技开发有限公司 | 一种三层含水胶囊及其制备方法 |
US11298336B2 (en) | 2019-05-30 | 2022-04-12 | Soluble Technologies, Inc. | Water soluble formulation |
CN113367379A (zh) * | 2020-03-09 | 2021-09-10 | 深圳波顿香料有限公司 | 一种烟草制品 |
US11786475B2 (en) | 2020-07-22 | 2023-10-17 | Soluble Technologies Inc. | Film-based dosage form |
CN115721627B (zh) * | 2022-11-10 | 2024-08-30 | 南通华山药业有限公司 | 一种益母草软胶丸及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0761948B2 (ja) * | 1986-05-08 | 1995-07-05 | フロイント産業株式会社 | 腸内有用細菌含有カプセル |
GB2290965A (en) * | 1994-07-11 | 1996-01-17 | Therapicon Srl | Multiple layer capsules for drugs |
DE4432557A1 (de) * | 1994-09-13 | 1996-03-14 | Hoechst Ag | Kapseln mit innenseitig hydrophober Beschichtung zur Aufnahme von matrixadsorbierten wäßrigen (radioaktiven) Lösungen und Verfahren zur Herstellung obiger Kapseln |
-
1996
- 1996-06-06 CA CA002222120A patent/CA2222120A1/en not_active Abandoned
- 1996-06-06 BR BR9608608-4A patent/BR9608608A/pt not_active Application Discontinuation
- 1996-06-06 WO PCT/US1996/009145 patent/WO1996040083A2/en not_active Application Discontinuation
- 1996-06-06 SK SK1648-97A patent/SK164897A3/sk unknown
- 1996-06-06 IL IL12242296A patent/IL122422A0/xx unknown
- 1996-06-06 EP EP96919128A patent/EP0837675A2/en not_active Withdrawn
- 1996-06-06 NZ NZ310708A patent/NZ310708A/xx unknown
- 1996-06-06 HU HU9900858A patent/HUP9900858A2/hu unknown
- 1996-06-06 KR KR1019970708924A patent/KR19990022443A/ko not_active Withdrawn
- 1996-06-06 PL PL96323790A patent/PL323790A1/xx unknown
- 1996-06-06 CZ CZ973818A patent/CZ381897A3/cs unknown
- 1996-06-06 JP JP9501535A patent/JPH11506785A/ja active Pending
- 1996-06-06 CN CN96194414A patent/CN1186429A/zh active Pending
- 1996-06-06 AU AU61546/96A patent/AU6154696A/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO9640083A2 * |
Also Published As
Publication number | Publication date |
---|---|
JPH11506785A (ja) | 1999-06-15 |
SK164897A3 (en) | 1998-12-02 |
BR9608608A (pt) | 1999-12-07 |
WO1996040083A3 (en) | 1997-02-06 |
AU6154696A (en) | 1996-12-30 |
CZ381897A3 (cs) | 1998-05-13 |
HUP9900858A2 (hu) | 1999-08-30 |
NZ310708A (en) | 1999-11-29 |
KR19990022443A (ko) | 1999-03-25 |
IL122422A0 (en) | 1998-06-15 |
PL323790A1 (en) | 1998-04-27 |
CA2222120A1 (en) | 1996-12-19 |
WO1996040083A2 (en) | 1996-12-19 |
CN1186429A (zh) | 1998-07-01 |
MX9709198A (es) | 1998-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996040083A2 (en) | Methods and compositions for preparing soft gelatin capsules having shells resistant to permeation by fill materials | |
CA1194797A (en) | Sustained release oral medicinal delivery device | |
FI97686B (fi) | Menetelmä helmien valmistamiseksi tarkoituksena tuottaa hallitusti vapauttavia tuotteita | |
US6306428B1 (en) | Time-release laminar pharmaceutical composition | |
CN103826843A (zh) | 用于包装饮食产品、化妆品和医药专用品的对湿气和氧气具有不可透过性的材料 | |
CN1747656A (zh) | 速溶剂型的包装和分配 | |
KR20050026518A (ko) | 용해도가 낮은 활성 성분을 변형 방출시키는 경구 전달용마이크로캡슐 | |
CZ148396A3 (en) | Preparation intended for controllable release of active compounds and the use thereof | |
JPS63501794A (ja) | 医薬有効物質,試薬,その他の作用物質の提供ないし投与形態の製造法 | |
JP4719354B2 (ja) | 個別層から成る積層体の製造方法 | |
CN1312710A (zh) | 成膜活性物质载体 | |
CA2000932C (en) | Oral pharmaceutical controlled release multiple unit dosage form | |
EP1667652B1 (en) | Improved controlled release dosage form including a banded engine | |
CN102821754A (zh) | 多层熔融挤出膜 | |
EP4151205B1 (en) | Self-adhesive patches made of fibres for the controlled release of bioactives | |
MXPA97009198A (en) | Methods and compositions for preparing soft degelatine capsules that have resistant coverings to permeation by rell materials | |
Cansell et al. | Stability of marine lipid based-liposomes under acid conditions. Influence of xanthan gum | |
KR20050083874A (ko) | 액상 제제의 방출을 증진시키는 제형 | |
CN100563726C (zh) | 粘合剂材料和粘合剂制剂 | |
WO1997034585A1 (en) | Transparent hard capsules | |
CN111449960A (zh) | 嵌套式胶囊及其制备方法 | |
DK175608B1 (da) | Hidtil ukendt doseringsform | |
JPH0815773B2 (ja) | 水分散性ポリビニルアルコール系ラミネートフィルムおよびその製造法 | |
RU98100233A (ru) | Способы и композиции для изготовления мягких желатиновых капсул, имеющих оболочки, устойчивые к проникновению наполняющих материалов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980107 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: LT PAYMENT 980107;LV PAYMENT 980107;SI PAYMENT 980107 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Withdrawal date: 20000121 |